Chuang D M, Costa E
Proc Natl Acad Sci U S A. 1979 Jun;76(6):3024-8. doi: 10.1073/pnas.76.6.3024.
In the supernatant (30,000 x g) of frog erythrocyte homogenates, by using gel filtration we detected a protein that could bind [(3)H]dihydroalprenolol ([(3)H]DHA) with high affinity. This binding was greatly enhanced when the erythrocytes were preincubated with (-)-isoproterenol. After various periods of incubation with (-)-isoproterenol, the extent of the increase in the density of [(3)H]DHA binding sites in the cytosol was paralleled by a proportional decrease in the number of [(3)H]DHA binding sites in the corresponding pellet; both events peaked after 2-3 hr of incubation with (-)-isoproterenol. The K(a) of the (-)-isoproterenol-induced increase in [(3)H]DHA binding in cytosol and the decrease in this binding in the membrane ranged between 60 and 90 nM. The changes in the cytosol and particulate [(3)H]DHA binding sites were independent of RNA and protein synthesis. The increase in cytosol binding elicited by (-)-isoproterenol was blocked by exposure of the cells to (-)-alprenolol which per se failed to change the cytosol binding of [(3)H]DHA. Scatchard analysis revealed that the enhanced [(3)H]DHA binding to cytosol material was due to a 4-fold increase in the B(max) with little or no change in K(d) ( approximately 9 nM). Binding displacement data show that these soluble [(3)H]DHA binding sites resemble the surface membrane recognition sites. Moreover, the ability of various beta-adrenergic agents to increase [(3)H]DHA binding to cytosol after they were incubated with frog erythrocytes paralleled their affinity for membrane-bound beta receptors. These findings support the view that the beta-adrenergic receptor desensitization caused by prolonged exposure to (-)-isoproterenol is due, at least in part, to an internalization of the recognition site of beta-adrenergic receptors.
在蛙红细胞匀浆的上清液(30,000×g)中,通过凝胶过滤我们检测到一种能与[³H]二氢阿普洛尔([³H]DHA)高亲和力结合的蛋白质。当红细胞与(-)-异丙肾上腺素预孵育时,这种结合显著增强。在与(-)-异丙肾上腺素孵育不同时间后,胞质溶胶中[³H]DHA结合位点密度增加的程度与相应沉淀中[³H]DHA结合位点数量的成比例减少相平行;这两个事件在与(-)-异丙肾上腺素孵育2 - 3小时后达到峰值。(-)-异丙肾上腺素诱导的胞质溶胶中[³H]DHA结合增加以及膜中这种结合减少的解离常数(Kₐ)在60至90 nM之间。胞质溶胶和颗粒状[³H]DHA结合位点的变化与RNA和蛋白质合成无关。(-)-异丙肾上腺素引起的胞质溶胶结合增加被细胞暴露于(-)-阿普洛尔所阻断,而(-)-阿普洛尔本身未能改变[³H]DHA的胞质溶胶结合。Scatchard分析表明,增强的[³H]DHA与胞质溶胶物质的结合是由于最大结合量(Bₘₐₓ)增加了四倍,而解离常数(Kd)(约9 nM)几乎没有变化。结合置换数据表明,这些可溶性[³H]DHA结合位点类似于表面膜识别位点。此外,各种β-肾上腺素能药物与蛙红细胞孵育后增加[³H]DHA与胞质溶胶结合的能力与它们对膜结合β受体的亲和力相平行。这些发现支持这样一种观点,即长时间暴露于(-)-异丙肾上腺素导致的β-肾上腺素能受体脱敏至少部分是由于β-肾上腺素能受体识别位点的内化。